However, the distribution of these mutations is different to the one observed in JMML patients harboring NRAS/KRAS somatic mutations, and the evidence pointing to a driver role in JMML leukemogenesis is scarce [30,31,32,33]. This evidence concerns the gene NRAS and juvenile myelomonocytic leukemia.